Therapeutic potential of a polymer-encapsulated L-DOPA and dopamine- producing cell line in rodent and primate models of Parkinson's disease

Cell Transplantation

Volumn 7, Issue 2, 1998, Pages 165-174

  Lindner, Mark D ^a   Emerich, Dwaine F ^b  

^a CytoTherapeutics Inc   (United States)

^b ALKERMES INC   (United States)

Author keywords

Animal models; Cell line; Encapsulation technology; Parkinson's disease; Potential efficacy; Transplantation

Indexed keywords

DOPAMINE; LEVODOPA; POLYMER;

ANIMAL CELL; ANIMAL MODEL; CELL TRANSPLANTATION; CONFERENCE PAPER; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ENCAPSULATION; MEDICAL ETHICS; NERVE TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

ANIMALS; BIOTECHNOLOGY; CELL TRANSPLANTATION; CORPUS STRIATUM; DIFFUSION CHAMBERS, CULTURE; DISEASE MODELS, ANIMAL; DOPAMINE; DRUG DELIVERY SYSTEMS; HUMANS; LEVODOPA; PARKINSON DISEASE; PC12 CELLS; POLYMERS; PRIMATES; RATS;

EID: 0031896991     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0963-6897(97)00169-3     Document Type: Conference Paper

References (87)

1. Aebischer, P.; Goddard, M.; Signore, A.P.; Timpson, R.L. Functional recovery in hemiparkinsonian primates transplanted with polymer-encapsulated PC 12 cells. Exp. Neurol. 126:151-158; 1994.
2. Aebischer, P.; Tresco, P.A.; Winn, S.R.; Greene, L.A.; Jaeger, C.B. Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line. Exp. Neurol. 111:269-275; 1991.
3. Ahlskog, J.E.; Kelly, P.J.; van Heerdene, J.A.; Stoddard, S.L.; Tyce, G.M.; Windebank, A.J.; Bailey, P.A.; Bell, G.N.; Blexrud, M.D.; Carmichael, S.W. Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: Clinical outcome and neurochemical studies. Mayo Clin. Proc. 65:305-328; 1990.
4. Barker, R.; Dunnett, S.B. Ibotenic acid lesions of the striatum reduce drug-induced rotation in the 6-hydroxydopamine-lesioned rat. Exp. Brain Res. 101:365-374; 1994.
5. Baroni, A.; Benvenuti, F.; Fantini, L.; Pantaleo, T.; Urbani, F. Human ballistic arm abduction movements: Effects of L-DOPA treatment in Parkinson's disease. Neurology 34: 868-876; 1984.
6. Bing, G.; Notter, M.F.D.; Hansen, J.T.; Gash, D.M. Comparison of adrenal medullary, carotid body and PC12 cell grafts in 6-OHDA lesioned rats. Brain Res. Bull. 20:399-406; 1988.
7. Birkmayer, W.; Riederer, P. Responsibility of extrastriatal areas for the appearance of psychotic symptoms (clinical and biochemical human postmortem findings). J. Neural Transm. 37:175-182; 1975.
8. Bjorklund, A.; Dunnett, S.B.; Stenevi, U.; Lewis, M.E.; Iversen, S.D. Reinnervation of the denervated striatum by substantia nigra transplants: Functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res. 199:307-333; 1980.
9. Chase, T.N.; Engber, T.M.; Mouradian, M.M. Palliative and prophylactic benefits of continuously administered dopaminomimetics in Parkinson's disease. Neurology 44: S15-S18; 1994.
10. Christenson, L.; Aebischer, P.; McMillan, P.; Galletti, P.M. Tissue reaction to intraperitoneal polymer implants: Species difference and effects of corticoid and doxorubicin. J. Biomed. Mater. Res. 23:705-718; 1989.
11. Creese, E.; Iversen, S.D. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res. 55:369-382; 1973.
12. Creese, I.; Burt, D.R.; Snyder, S.H. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science 197:596-598; 1977.
13. Creese, I.; Iversen, S.D. The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res. 83:419-436; 1975.
14. Date, I.; Felten, S.Y.; Felten, D.L. Cografts of adrenal medulla with peripheral nerve enhance the survivability of transplanted adrenal chromaffin cells and recovery of the host nigrostriatal dopaminergic system in MPTP-treated young adult mice. Brain Res. 537:33-39; 1990.
15. Date, I.; Imaoka, T.; Miyoshi, Y.; Ono, T.; Asari, S.; Ohmoto, T. Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla pretransected peripheral nerve. J. Neurosurg. 84:685-689; 1996.
16. Defer, G.L.; Geny, C.; Ricolfi, F.; Fenelon, G.; Monfort, J.C.; Remy, P.; Villafane, G.; Jeny, R.; Samson, Y.; Keravel, Y.; Gaston, A.; Degos, J.D.; Peschanski, M.; Cesaro, P.; Nguyen, J.P. Long-term outcome of unilaterally transplanted Parkinsonian patients. 1. Clinical approache. Brain 119:41-50; 1996.
17. Delaney, P.; Fermaglich, J. Parkinsonism and levodopa: A five-year experience. J. Clin. Pharmacol. 16:652-659; 1976.
18. Dirocco, A.; Molinari, S.P.; Kollmeier, B.; Yahr, M.D. Parkinson's disease: Progression and mortality in the L-DOPA era. In: Battistin, L.; Scarlato, G.; Caraceni, T.; Ruggieri, S., eds. Parkinson's disease. Philadelphia: Lippincott-Raven; 1996:3-11.
19. Dunnett, S.B.; Bjorklund, A.; Schmidt, R.H.; Stenevi, U.; Iversen, S.D. Intracerebral grafting of neuronal cell suspensions IV. Behavioural recovery in rats with unilateral 6-OHDA lesions following implantation of nigral cell suspensions in different forebrain sitese. Acta Physiol. Scand. (Suppl.) 522:29-37; 1983.
20. Dunnett, S.B.; Bjorklund, A.; Stenevi, U.; Iversen, S.D. Behavioural recovery following transplantion of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. I. Unilateral lesionse. Brain Res. 215:147-161; 1981.
21. Dunnett, S.B.; Bjorklund, A.; Stenevi, U.; Iversen, S.D. Grafts of embryonic nigra reinnervating the ventrolateral striatum ameliorate sensorimotor impairments and akinesia in rats with 6-OHDA lesions of the nigrostriatal pathway. Brain Res. 229:209-217; 1981.
22. During, M.J.; Naegele, J.R.; Omalley, K.L.; Geller, A.I. Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266: 1399-1403; 1994.
23. Emerich, D.F.; Frydel, B.R.; Flanagan, T.R.; Palmatier, M.; Winn, S.R.; Christensen, L. Transplantation of polymer encapsulated PC12 cells: Use of chitosan as an immobilization matrix. Cell Transplant. 2:241-249; 1993.
24. Emerich, D.F.; Lindner, M.D.; Winn, S.R. Behavioral assessment of cell graft function in motor systems. In: Ricordi, C., ed. Methods in cell transplantation: Section on neural and paraneuronal cells, xxxx: The RG Landes Company; 1995:345-356.
25. Emerich, D.F.; McDermott, P.E.; Krueger, P.M.; Frydel, B.; Sanberg, P.R.; Winn, S.R. Polymer-encapsulated PC12 cells promote recovery of motor function in aged rats. Exp. Neurol. 122:37-47; 1993.
26. Emerich, D.F.; McDermott, P.E.; Krueger, P.M.; Winn, S.R. Intrastriatal implants of polymer-encapsulated PC12-cells-Effects on motor function in aged rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 18:935-946; 1994.
27. Emerich, D.F.; Winn, S.R.; Christenson, L.; Palmatier, M.A.; Gentile, F.T.; Sanberg, P.R. A novel approach to neural transplantation in Parkinson's disease: Use of polymer-encapsulated cell therapy. Neurosci. Biobehav. Rev. 16:437-447; 1992.
28. Emerich, D.F.; Winn, S.R.; Lindner, M.D. Continued presence of intrastriatal but not intraventricular polymer-encapsulated PC12 cells is required for alleviation of behavioral deficits in Parkinsonian rodents. Cell Transplant. 5:589-596; 1996.
29. Fairley, P.C.; Marshall, J.F. Dopamine in the lateral caudate-putamen of the rat is essential for somatosensory orientation. Behav. Neurosci. 100:652-663; 1986.
30. Freed, W.J.; Geller, H.M.; Poltorak, M.; Cannon-Spoor, H.E.; Cottingham, S.L.; LaMarca, M.E.; Schultzberg, M.; Rehavi, M.; Paul, S.; Ginns, E.I. Genetically altered and defined cell lines for transplantation in animal models of Parkinson's disease. Prog. Brain Res. 82:11-21; 1990.
31. Freed, W.J.; Patel-Vaidya, U.; Geller, H.M. Properties of PC12 pheochromocytoma cells transplanted to the adult rat brain. Exp. Brain Res. 63:557-566; 1986.
32. Goetz, C.G.; Tanner, C.M.; Penn, R.D.; Stebbins, G.T.; Gilley, D.W.; Shannon, K.M.; Klawans, H.L.; Comella, C.L.; Wilson, R.S.; Witt, T. Adrenal medullary transplant to the striatum of patients with advanced Parkinson's disease: 1-year motor and psychomotor data. Neurology 40:273-276; 1990.
33. Greene, L.A.; Tischler, A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73:2424-2428; 1976.
34. Hargreaves, E.L.; Cain, D.P.; Vanderwolf, C.H. Learning and behavioral-long-term potentiation: Importance of controlling for motor activity. J. Neurosci. 10:1472-1478; 1990.
35. Hefti, F.; Hartikka, J.; Schlumpf, M. Implantation of PC12 cells into the corpus striatum of rats with lesions of the dopaminergic nigrostriatal neurons. Brain Res. 348:283-288; 1985.
36. Hornykiewicz, O. Parkinson's disease and its chemotherapy. Biochem. Pharmacol. 24:1061-1065; 1975.
37. Hughes, A.J.; Daniel, S.E.; Blankson, S.; Lees, A.J. A clinicopathologic study of 100 cases of Parkinson's disease. Arch. Neurol. 50:140-148; 1993.
38. Isacson, O. Behavioral effects and gene delivery in a rat model of Parkinson's disease. Science 269:856; 1995.
39. Jaeger, C.B. Immunocytochemical study of PC12 cells grafted to the brain of immature rats. Exp. Brain Res. 59:615-624; 1985.
40. Kadar, T.; Silbermann, M.; Brandeis, R.; Levy, A. Age-related structural changes in the rat hippocampus: Correlation with working memory deficiency. Brain Res. 512: 113-120; 1990.
41. Kempster, P.A.; Frankel, J.P.; Stern, G.M.; Lees, A.J. Comparison of motor response to apomorphine and levodopa in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 53:1004-1007; 1990.
42. Kordower, J.H.; Goetz, C.G.; Freeman, T.B.; Olanow, C.W. Dopaminergic transplants in patients with Parkinson's disease: Neuroanatomical correlates of clinical recovery. Exp. Neurol. 144:41-46; 1997.
43. Kordower, J.H.; Liu, Y.T.; Winn, S.; Emerich, D.F. Encapsulated PC12 cell transplants into hemiparkinsonian monkeys: A behavioral, neuroanatomical, and neurochemical analysis. Cell Transplant. 4:155-171; 1995.
44. Lees, A.J. Dopamine agonists in Parkinson's disease: A look at apomorphine. Fundam. Clin. Pharmacol. 7:121-128; 1993.
45. Lindner, M.D.; Kearns, C.E.; Winn, S.R.; Frydel, B.; Emerich, D.F. Effects of intraventricular encapsulated hNGF-secreting fibroblasts in aged rats. Cell Transplant. 5:205-223; 1996.
46. Lindner, M.D.; Plone, M.A.; Francis, J.M.; Blaney, T.J.; Salamone, J.D.; Emerich, D.F. Rats with partial striatal dopamine depletions exhibit robust and long-lasting behavioral deficits in a simple fixed-ratio bar-pressing task. Behav. Brain Res. 86:25-40; 1997.
47. Lindner, M.D.; Plone, M.A.; Francis, J.M.; Emerich, D.F. Validation of a rodent model of Parkinson's disease: Evidence of a therapeutic window for oral Sinemet. Brain Res. Bull. 39:367-372; 1996.
48. Lindner, M.D.; Plone, M.A.; Mullins, T.D.; Winn, S.R.; Chandonait, S.E.; Stott, J.A.; Blaney, T.J.; Sherman, S.S.; Emerich, D.F. Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral Sinemet in rats. Exp. Neurol. 145:130-140; 1997.
49. Lindner, M.D.; Winn, S.R.; Baetge, E.E.; Hammang, J.P.; Gentile, F.T.; Doherty, E.; McDermott, P.E.; Frydel, B.; Ullman, M.D.; Schallert, T.; Emerich, D.F. Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms. Exp. Neurol. 132:62-76; 1995.
50. Lindvall, O.; Brundin, P.; Widner, H.; Rehncrona, S.; Gustavii, B.; Frackowiak, R.; Leenders, K.L.; Sawle, G.; Rothwell, J.C.; Marsden, C.D. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577; 1990.
51. Lindvall, O.; Rehncrona, S.; Brundin, P.; Gustavii, B.; Astedt, B.; Widner, H.; Lindholm, T.; Bjorklund, A.; Leenders, K.L.; Rothwell, J.C. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch. Neurol. 46:615-631; 1989.
52. Lindvall, O.; Sawle, G.; Widner, H.; Rothwell, J.C.; Bjorklund, A.; Brooks, D.; Brundin, P.; Frackowiak, R.; Marsden, C.D.; Odin, P.; Rehncrona, S. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinsons disease. Ann. Neurol. 35:172-180; 1994.
53. Lindvall, O.; Widner, H.; Rehncrona, S.; Brundin, P.; Odin, P.; Gustavii, B.; Frackowiak, R.; Leenders, K.L.; Sawle, G.; Rothwell, J.C. Transplantation of fetal dopamine neurons in Parkinson's disease: One-year clinical and neurophysiological observations in two patients with putaminal implants. Ann. Neurol. 31:155-165; 1992.
54. Lloyd, K.G. CNS compensation to dopamine neuron loss in Parkinson's disease. Adv. Exp. Med. Biol. 90:255-266; 1977.
55. Lopezlozano, J.J.; Bravo, G.; Brera, B.; Millan, I.; Dargallo, J.; Salmean, J.; Uria, J.; Insausti, J.; Martinez, R.; Delatorre, C.; Moreno, R. Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. J. Neurosurg. 86:931-942; 1997.
56. Luquin, M.R.; Scipioni, O.; Vaamonde, J.; Gershanik, O.; Obeso, J.A. Levodopa-induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification. Movement Disord. 7:117-124; 1992.
57. Marsden, C.D. The mysterious motor function of the basal ganglia: The Robert Warternberg Lecture. Neurology 32: 514-539; 1982.
58. Marshall, J.F. Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: Spontaneous recovery and pharmacological control. Brain Res. 177: 311-324; 1979.
59. Marshall, J.F.; Gotthelf, T. Sensory inattention in rats with 6-hydroxydopamine-induced degeneration of ascending dopaminergic neurons: Apomorphine-induced reversal of deficits. Exp. Neurol. 65:398-411; 1979.
60. Marshall, J.F.; Ungerstedt, U. Striatal efferent fibers play a role in maintaining rotational behavior in the rat. Science 198:62-64; 1977.
61. Mouradian, M.M.; Heuser, I.J.E.; Baronti, F.; Chase, T.N. Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parksinson's disease. Ann. Neurol. 27:18-23; 1990.
62. Muenter, M.D. Initial treatment of Parkinson's disease. Clin. Neuropharmacol. 5:S2-S12; 1982.
63. Olsson, M.; Nikkhah, G.; Bentlage, C.; Bjorklund, A. Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J. Neurosci. 15:3863-3875; 1995.
64. Perlow, M.J.; Freed, W.J.; Hoffer, B.J.; Seiger, A.; Olson, L.; Wyatt, R.J. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204:643-647; 1979.
65. Philpott, L.M.; Kopyov, O.V.; Lee, A.J.; Jacques, S.; Duma, C.M.; Caine, S.; Yang, M.; Eagle, K.S. Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: Three case presentations. Cell Transplant. 6:203-212; 1997.
66. Reading, P.J.; Dunnett, S.B. 6-Hydroxydopamine lesions of nigrostriatal neurons as an animal model of Parkinson's disease. In: Woodruff, M.L.; Nonneman, A.J., eds. Toxin-induced models of neurological disorders. New York: Plenum Press; 1994:89-119.
67. Riederer, P.; Wuketich, S. Time course of nigrostriatal degeneration in Parkinson's disease. J. Neural Transm. 38:277-301; 1976.
68. Robinson, T.E.; Becker, J.B. The rotational behavior model: Asymmetry in the effects of unilateral 6-OHDA lesions of the substantia nigra in rats. Brain Res. 264:127-131; 1983.
69. Rogers, M.W.; Chan, C.W.Y. Motor planning is impaired in Parkinson's disease. Brain Res. 438:271-276; 1988.
70. Scatton, B.; Rouquier, L.; Javoy-Agid, F.; Agid, Y. Dopamine deficiency in the cerebral cortex in Parkinson disease. Neurology 32:1039-1040; 1982.
71. Schallert, T.; De Rycke, M.; Whishaw, I.Q.; Ramirez, V.D.; Teitelbaum, P. Excessive bracing reactions and their control by atropine and L-DOPA in an animal analog of Parkinsonism. Exp. Neurol. 64:33-43; 1979.
72. Schallert, T.; Jones, T.A.; Norton, D. A clinically relevant unilateral rat model of Parkinsonian akinesia. J. Neural Transplant. Plast. 3:332-333; 1992.
73. Schallen, T.; Whishaw, I.Q.; Ramirez, V.D.; Teitelbaum, P. Compulsive, abnormal walking caused by anticholinergics in akinetic, 6-hydroxydopamine-treated rats. Science 199:1461-1463; 1978.
74. Schelosky, L.; Poewe, W. Current strategies in the drug treatment of advanced Parkinson's disease - New modes of dopamine substitution. Fundam. Clin. Pharmacol. 7:121-128; 1993.
75. Schwab, R.S.; Zieper, I. Effects of mood, motivation, stress and alertness on the performance in Parkinson's disease. Psychiatr. Neurol. 150:345-357; 1965.
76. Stenevi, U.; Bjorklund, A.; Dunnett, S.B. Functional reinnervation of the denervated neostriatum by nigral transplants. Peptides 1(Suppl. 1):111-116; 1980.
77. Stocchi, F.; Bonamartini, A.; Vacca, L.; Ruggieri, S. Motor fluctuations in levodopa treatment: Clinical pharmacology. Eur. Neurol. 36:38-42; 1996.
78. Stromberg, I.; Herrera-Marschitz, M.; Ungerstedt, U.; Ebendal, T.; Olson, L. Chronic implants of chromaffin tissue into the dopamine-denervated striatum. Effects of NGF on graft survival, fiber growth and rotational behaviore. Exp. Brain Res. 60:335-349; 1985.
79. 18F-DOPA uptake and metabolism after intracerebral implantation in nonhuman primates. Cell Transplant. 6:469-477; 1997.
80. Tresco, P.A.; Winn, S.R.; Aebischer, P. Polymer encapsulated neurotransmitter secreting cells: Potential treatment for Parkinson's disease. ASAIO J. 38:17-23; 1992.
81. Tresco, P.A.; Winn, S.R.; Tan, S.; Jaeger, C.B.; Greene, L.A.; Aebischer, P. Polymer-encapsulated PC12 cells: Long-term survival and associated reduction in lesion-induced rotational behavior. Cell Transplant. 1:255-264; 1992.
82. Wenning, G.K.; Odin, P.; Morrish, P.; Rehncrona, S.; Widner, H.; Brundin, P.; Rothwell, J.C.; Brown, R.; Gustavii, B.; Hagell, P.; Jahanshahi, M.; Sawle, G.; Bjorklund, A.; Brooks, D.J.; Marsden, C.D.; Quinn, N.P.; Lindvall, O. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42:95-107; 1997.
83. Westlund, K.N.; Lu, Y.; Kadekaro, M.; Harmann, P.; Terrell, M.L.; Pizzo, D.P.; Hulsebosch,' C.E.; Eisenberg, H.M.; Perezpolo, J.R. NGF-producing transfected 3T3 cells: Behavioral and histological assessment of transplants in nigral lesioned rats. J. Neurosci. Res. 41:367-373; 1995.
84. Winn, S.R.; Aebischer, P.; Galletti, P.M. Brain tissue reaction to permselective polymer capsules. J. Biomed. Mater. Res. 23:31-44; 1989.
85. Winn, S.R.; Tresco, P.A.; Zielinski, B.; Greene, L.A.; Jaeger, C.B.; Aebischer, P. Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells. Exp. Neurol. 113:322-329; 1991.
86. Winn, S.R.; Tresco, P.A.; Zielinski, B.; Sagen, J.; Aebischer, P. Microencapsulated bovine chromaffin cells in vitro: Effect of density and coseeding with a NGF-releasing cell line. J. Neural Transplant. Plast. 3:115-124; 1992.
87. Zabek, M.; Mazurowski, W.; Dymecki, J.; Stelmachow, J.; Zawada, E. A long term follow-up of fetal dopaminergic neurons transplantation into the brain of three Parkinsonian patients. Restor. Neurol. Neurosci. 6:97-106; 1994.